Westerkirk Capital Inc.

Position in MRK — Merck & Co., Inc.

CIK 2080423 VICTORIA, A1

Position in MRK

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$5,975,250

+$153,214 QoQ

Shares Held

46,500

-3.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.84%

of 13F equity value

Holder Rank

#961

of 3,769 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Westerkirk Capital Inc. holds $40,505,317 across 6 Drug Manufacturers - General names. MRK ranks #3 (14.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	13,207	$15,840,873
2	JNJ	Johnson & Johnson	38,959	$9,894,417
3	MRK	Merck & Co., Inc. This page	46,500	$5,975,250
4	AZN	Astrazeneca PLC	28,729	$5,447,592
5	GILD	Gilead Sciences, Inc.	25,686	$3,245,169
6	NVO	Novo Nordisk A S	2,128	$102,016

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,975,250	46,500	-3.9%	Shares	Sole	2026-08-10
2026-03-31	$5,822,036	48,400	-2.4%	Shares	Sole	2026-05-14
2025-12-31	$5,220,896	49,600	+4.4%	Shares	Sole	2026-02-11
2025-09-30	$3,986,675	47,500	+42.2%	Shares	Sole	2025-11-10
2025-06-30	$2,643,944	33,400	—	Shares	Sole	2025-08-13
No filing history on record for this holder in this stock.